Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer's Disease: Dissociation between Somatosensory Cortex and Hippocampus

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Crouzin, Nadine ^a,b   Baranger, Kevin ^a,b   Cavalier, Mélanie ^c   Marchalant, Yannick ^a,b   Cohen Solal, Catherine ^c   Roman, François S ^a,b   Khrestchatisky, Michel ^a,b   Rivera, Santiago ^a,b   Féron, François ^a,b   Vignes, Michel ^c  

^a Mediterranée University   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; SOMATOSENSORY CORTEX; SYNAPTIC TRANSMISSION; WILD TYPE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MALE; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; PLAQUE, AMYLOID; SOMATOSENSORY CORTEX; SYNAPTIC TRANSMISSION;

EID: 84884254543     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074667     Document Type: Article

References (54)

1. Selkoe DJ, Schenk D, (2003) Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43: 545-584. doi:10.1146/annurev.pharmtox.43.100901.140248. PubMed: 12415125.
2. Duyckaerts C, Delatour B, Potier MC, (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118: 5-36. PubMed: 19381658.
3. Ashe KH, (2001) Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem 8: 301-308. PubMed: 11773429.
4. Eriksen JL, Janus CG, (2007) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 37: 79-100. PubMed: 17072762.
5. Spires TL, Hyman BT, (2005) Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2: 423-437. PubMed: 16389306.
6. Kimura R, Ohno M, (2009) Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 33: 229-235. doi:10.1016/j.nbd.2008.10.006. PubMed: 19026746.
7. Oakley H, Cole SL, Logan S, Maus E, Shao P, et al. (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26: 10129-10140. PubMed: 17021169.
8. Ohno M, (2006) Genetic and pharmacological basis for therapeutic inhibition of beta- and gamma-secretases in mouse models of Alzheimer's memory deficits. Rev Neurosci 17: 429-454. PubMed: 17139843.
9. Hongpaisan J, Sun MK, Alkon DL, (2011) PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer's disease transgenic mice. J Neurosci 31: 630-643. PubMed: 21228172.
10. Devi L, Ohno M, (2010) Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Eur J Neurosci 31: 110-118. PubMed: 20092558.
11. Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, et al. (2012) Evidence for Early Cognitive Impairment Related to Frontal Cortex in the 5XFAD Mouse Model of Alzheimer's Disease. J Alzheimers Dis, 33: 781-96. PubMed: 23042214.
12. Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O, (2012) Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging 33196:: e129-e140.
13. Ohno M, (2009) Failures to reconsolidate memory in a mouse model of Alzheimer's disease. Neurobiol Learn Mem 92: 455-459. PubMed: 19435612.
14. McGowan E, Eriksen J, Hutton M, (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 22: 281-289. doi:10.1016/j.tig.2006.03.007. PubMed: 16567017.
15. Lynch MA, (2004) Long-term potentiation and memory. Physiol Rev 84: 87-136. PubMed: 14715912.
16. Dudai Y, (2004) The neurobiology of consolidations, or, how stable is the engram? Annu Rev Psychol 55: 51-86. PubMed: 14744210.
17. Frankland PW, Bontempi B, (2005) The organization of recent and remote memories. Nat Rev Neurosci 6: 119-130. PubMed: 15685217.
18. McClelland JL, McNaughton BL, O'Reilly RC, (1995) Why there are complementary learning systems in the hippocampus and neocortex: insights from the successes and failures of connectionist models of learning and memory. Psychol Rev 102: 419-457. PubMed: 7624455.
19. Squire LR, Bayley PJ, (2007) The neuroscience of remote memory. Curr Opin Neurobiol 17: 185-196. PubMed: 17336513.
20. Götz J, Ittner LM, (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9: 532-544. PubMed: 18568014.
21. Carlesimo GA, Oscar-Berman M, (1992) Memory deficits in Alzheimer's patients: a comprehensive review. Neuropsychol Rev 3: 119-169. PubMed: 1300219.
22. Hom J, (1992) General and specific cognitive dysfunctions in patients with Alzheimer's disease. Arch Clin Neuropsychol 7: 121-133. PubMed: 14589636.
23. Ben Achour S, Pascual O, (2010) Glia: the many ways to modulate synaptic plasticity. Neurochem Int 57: 440-445. PubMed: 20193723.
24. Lanté F, Crouzin N, Vignes M, (2008) Unveiling novel forms of hippocampal synaptic plasticity with microelectrode arrays. J Integr Neurosci 7: 249-270. doi:10.1142/S0219635208001800. PubMed: 18763723.
25. Heuschkel MO, Fejtl M, Raggenbass M, Bertrand D, Renaud P, (2002) A three-dimensional multi-electrode array for multi-site stimulation and recording in acute brain slices. J Neurosci Methods 114: 135-148. PubMed: 11856564.
26. Kopanitsa MV, Afinowi NO, Grant SG, (2006) Recording long-term potentiation of synaptic transmission by three-dimensional multi-electrode arrays. BMC Neurosci 7: 61. doi:10.1186/1471-2202-7-61. PubMed: 16942609.
27. Zucker RS, Regehr WG, (2002) Short-term synaptic plasticity. Annu Rev Physiol 64: 355-405. doi:10.1146/annurev.physiol.64.092501.114547. PubMed: 11826273.
28. Gerlai R, (2002) Hippocampal LTP and memory in mouse strains: is there evidence for a causal relationship? Hippocampus 12: 657-666. doi:10.1002/hipo.10101. PubMed: 12440580.
29. Nguyen PV, (2006) Comparative plasticity of brain synapses in inbred mouse strains. J Exp Biol 209: 2293-2303. PubMed: 16731805.
30. Nguyen PV, Abel T, Kandel ER, Bourtchouladze R, (2000) Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice. Learn Mem 7: 170-179. doi:10.1101/lm.7.3.170. PubMed: 10837506.
31. Braak H, Braak E, (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259. doi:10.1007/BF00308809. PubMed: 1759558.
32. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G, (2001) Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 22: 1030-1036. PubMed: 11415893.
33. Stephen JM, Montaño R, Donahue CH, Adair JC, Knoefel J, et al. (2010) Somatosensory responses in normal aging, mild cognitive impairment, and Alzheimer's disease. J Neural Transm 117: 217-225. PubMed: 20013008.
34. Marchetti C, Marie H, (2011) Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? Rev Neurosci 22: 373-402. PubMed: 21732714.
35. Battaglia F, Wang HY, Ghilardi MF, Gashi E, Quartarone A, et al. (2007) Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 62: 1405-1412. PubMed: 17651702.
36. Kimura R, Devi L, Ohno M, (2010) Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J Neurochem 113: 248-261. PubMed: 20089133.
37. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, et al. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2: 271-276. doi:10.1038/6374. PubMed: 10195221.
38. Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, et al. (2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci 21: 4691-4698. PubMed: 11425896.
39. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, et al. (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55: 697-711. doi:10.1016/j.neuron.2007.07.025. PubMed: 17785178.
40. Buzsáki G, (2002) Theta oscillations in the hippocampus. Neuron 33: 325-340. doi:10.1016/S0896-6273(02)00586-X. PubMed: 11832222.
41. Castro-Alamancos MA, Connors BW, (1996) Short-term synaptic enhancement and long-term potentiation in neocortex. Proc Natl Acad Sci U S A 93: 1335-1339. PubMed: 8577765.
42. Hernandez RV, Navarro MM, Rodriguez WA, Martinez JL Jr., LeBaron RG, (2005) Differences in the magnitude of long-term potentiation produced by theta burst and high frequency stimulation protocols matched in stimulus number. Brain Res Protoc 15: 6-13.
43. Gonatas NK, Anderson W, Evangelista I, (1967) The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementia. J Neuropathol Exp Neurol 26: 25-39. PubMed: 6022163.
44. Delatour B, Blanchard V, Pradier L, Duyckaerts C, (2004) Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiol Dis 16: 41-47. doi:10.1016/j.nbd.2004.01.008. PubMed: 15207260.
45. Chang PK, Verbich D, McKinney RA, (2012) AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook. Eur J Neurosci 35: 1908-1916. PubMed: 22708602.
46. Johnson MA, Lombroso PJ, (2012) A common STEP in the synaptic pathology of diverse neuropsychiatric disorders. Yale J Biol Med 85: 481-490. PubMed: 23239949.
47. Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, et al. (2010) Alzheimer's disease amyloid beta-protein and synaptic function. Neuromol Med 12: 13-26. PubMed: 19757208.
48. Esiri MM, Chance SA, (2006) Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organization. J Alzheimers Dis 9: 79-89. PubMed: 16914847.
49. Koliatsos VE, Kecojevic A, Troncoso JC, Gastard MC, Bennett DA, et al. (2006) Early involvement of small inhibitory cortical interneurons in Alzheimer's disease. Acta Neuropathol 112: 147-162. PubMed: 16758165.
50. León-Espinosa G, DeFelipe J, Muñoz A, (2012) Effects of amyloid-beta plaque proximity on the axon initial segment of pyramidal cells. J Alzheimers Dis 29: 841-852. PubMed: 22337828.
51. Ramos B, Baglietto-Vargas D, del Rio JC, Moreno-Gonzalez I, Santa-Maria C, et al. (2006) Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease. Neurobiol Aging 27: 1658-1672. PubMed: 16271420.
52. Verret L, Mann EO, Hang GB, Barth AM, Cobos I, et al. (2012) Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149: 708-721. PubMed: 22541439.
53. Bell KF, Claudio Cuello A, (2006) Altered synaptic function in Alzheimer's disease. Eur J Pharmacol 545: 11-21. doi:10.1016/j.ejphar.2006.06.045. PubMed: 16887118.
54. Bell KF, Ducatenzeiler A, Ribeiro-da-Silva A, Duff K, Bennett DA, et al. (2006) The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 27: 1644-1657. PubMed: 16271419.